NCT01318369View on ClinicalTrials.gov

Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
CannabinoidTetrahydrocannabinolChronic PancreatitisAbdominal Pain
Interventions
DRUG

Namisol

Single dose delta-9-tetrahydrocannabinol

DRUG

Diazepam

Diazepam single dose 5mg in subgroup non-opioid users and 10 mg in subgroup opioid users.

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01318369 - Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain | Biotech Hunter | Biotech Hunter